Deletions in the 8p21-22 region of the human genome are among the most common genetic alterations in prostate carcinomas. Several studies in dierent tumor tissues, including prostate, indicate that there are probably multiple tumor suppressor genes (TSGs) present in this region. To identify candidate TSGs on 8p22 a YAC contig spanning this region was assembled and YAC clones retro®tted with a selectable marker (neo) were transferred into rat prostate AT6.2 cells. Two overlapping YAC clones showed greatly reduced colonyforming eciency, indicating they may carry a TSG. Two BAC clones encompassing the overlapping region also appeared to exert suppressive eects on the growth of AT6.2 cells. Database searches for genes mapped to the critical region identi®ed a gene known as FEZ1 (LZTS1) as a potential candidate suppressor gene. Subsequent experiments showed that over-expression of LZTS1 cDNA inhibited stable colony-forming eciencies of AT6.2, HEK-293 and LNCaP cells. In contrast, LZTS1-transfected Rat-1 and RM1 cells were growthstimulated. Database searches also identi®ed additional isoforms of the LZTS1 mRNA, as well as LZTS1 protein domains reminiscent of those found in transcription factors. Together these data suggest that the LZTS1 gene is involved in the regulation of cell growth and its loss of function may contribute to the development of prostatic carcinomas, as well as other cancers. Oncogene (2001) 20, 4169 ± 4179.
Introduction
One of the most intensely studied areas of cancer research in recent years has been that of tumor suppressor genes (Anderson and Stanbridge, 1993) . Fusion of normal and malignant cells aorded the ®rst evidence that the normal genome may restore the responsiveness of tumor cells to growth controls (Harris et al., 1969) . Subsequently, the technique of microcell fusion has been widely used to achieve reversion of the malignant phenotype of certain tumor cells by introducing single normal human chromosomes or subchromosomal fragments (Goyette et al., 1992; Ichikawa et al., 1994; Murakami et al., 1996) . Even tumors that have arisen through multiple genetic alterations on dierent chromosomes have been reverted to a less tumorigenic phenotype, indicating that introduction of a single TSG may be sucient to suppress tumor growth. More recently, functional complementation using YAC clones has been used successfully to further localize putative TSGs to individual YACs, which are more amenable to positional cloning approaches (Koreth et al., 1999; Murakami et al., 1998; Reddy et al., 2000) .
Loss of heterozygosity (LOH) and homozygous deletions at the human chromosome 8p region are among the most common genetic alterations in prostate adenocarcinomas and other cancer tumors Farrington et al., 1996; Kagan et al., 1995) . These studies suggest that at least two dierent TSGs reside in the 8p21-22 region. Transfer into cancer cells has provided further evidence that this chromosomal region harbors genes that suppress tumorigenicity (Ichikawa et al., 1994; Murakami et al., 1996) . Positional cloning methods have led to the isolation of at least three genes localized to 8p21-22, PDGFRL (also known as PRLTS; Fujiwara et al., 1995) , NKX3.1 (Bhatia-Gaur et al., 1999) and N33 , that have been postulated as candidate cancer genes. More recently, another gene from 8p22, referred to as FEZ1 (F37/Esophageal cancer-related genecoding leucine-zipper motif), has been isolated and found to be altered in several tumors including esophageal, breast and prostate (Ishii et al., 1999) . The HUGO Human Gene Nomenclature committee has now designated this locus as the LZTS1 (leucine zipper, putative tumor suppressor 1) gene.
We have used YAC-based and BAC-based transfection approaches to narrow down the regions carrying genes that decrease stable colony-forming eciency of tumor cells or aect their growth properties. Using this approach a putative TSG locus was mapped to individual YAC and BAC clones in the 8p22 region. Subsequently, database searches with STS and EST markers identi®ed LZTS1 as a candidate TSG located inside the critical region. Subsequent analysis of the eects of over-expression of LZTS1 on colony formation and cell growth suggests that LZTS1 is, in fact, the gene responsible for the observed growth inhibitory eects on rat AT6.2 cells and two human cell lines. In contrast, this gene stimulated growth of some other cell lines studied.
Results

YACs and BACs from 8p22 reduce colony-forming efficiency of AT6.2 cells
Using chromosome 8p STS markers, we constructed an extensive contig of more than 80 YACs encompassing the whole 8p22 region, as described in Materials and methods. An overlapping set of nine YACs, indicated in Figure 1a , was retro®tted with a neo selectable marker using the pRAN4 vector and these clones were proven to be correctly targeted by gel electrophoresis and PCR analyses (data not shown). Seven of these YAC clones were successfully used for transfection by fusion to AT6.2 rat prostate tumor cells. After selection in G418, numerous discrete colonies were observed in some of the plates from each of the YAC transfections. Generally, the frequency of G418 r colonies in these plates was similar to that observed by others (Pachnis et al., 1990) . However, a substantial dierence between two overlapping YACs (911G7 and 739B2) and the other ®ve YACs was observed in the number of colonies on the plates. This observation prompted us to assess the frequency of introduction of YAC sequences into AT6.2 cells by categorizing the plates according to the number and size of the G418 r colonies in each plate. The results, shown in Figure 1b , indicated that the plates with very few small colonies or no colonies comprised more than 90% of the total number of plates for the 911G7 YAC fusion clones and around 65% for the 739B2 YAC fusion clones. In fact, as shown in Figure 1b , the characteristics of the colonies observed after transfection with these two YACs resembled those observed using YAC 204E7, which contains the TP53 gene. With this clone, which was used as a TSG control, a majority of the plates not only showed reduction in the number of colonies produced, but, also, the colonies that did form were signi®cantly smaller (530 cells per colony). In contrast, plates with a relatively large number of colonies comprised more than 80% of the total number of plates for the other YAC fusion clones. Most surviving clones derived from colonies transformed with YAC 911G7 showed little increase in cell number after a week, whereas clones transformed with other YACs showed at least a ®vefold expansion (not shown).
Next, a BAC contig encompassing the overlapping region of the 911G7 and 739B2 YACs was constructed using overgo probes designed from sequences of a set of 10 STS and EST markers that were previously mapped into this region; at least 20 BACs that mapped to this region were identi®ed. The three BACs shown in Figure 1c were selected to study eects on growth properties of AT6.2 cells. Because most BAC libraries have been constructed in vectors that do not carry a mammalian selectable marker, transfection and selection of stable clones typically requires time-consuming clone modi®cation. Instead, we used a simpler approach to rapidly identify BACs that exert suppressive eects on AT6.2 cells. BACs were co-transfected with a GFP reporter BAC of similar size into the AT6.2 cells using a method that allows the ecient delivery of large DNA molecules into cells through the use of psoralen-inactivated adenoviral particles and PEI (Baker and Cotten, 1997) . The cell growth suppressive eects and/or cytotoxic eects of these BACs on AT6.2 cells were assessed by simply monitoring the decrease in GFP+ cells for a period of 5 days post-transfection, as previously described (Zeng et al., 1997) . Representative ®elds observed on days 1 and 5 following BAC transfection are shown in Figure 1d . Two of the BACs (CTI-B 353G1 and CTI-B 316F10) appeared to exert eects on AT6.2 cells that were similar to those observed with the two overlapping YACs. These results allowed us to further minimize the region containing the putative TSG to approximately 160 Kb. Together the results from the transfection experiments with YACs and BACs from the 8p22 critical region indicated that this region harbors a gene that negatively regulates AT6.2 cell growth.
Identification of LZTS1 as a potential TSG in the YAC overlap region
To identify the gene(s) responsible for the cell growth inhibitory eect, we compiled sequencing and mapping data from several sources and constructed an integrated map of this minimal 8p22 subregion, as shown in Figure 2a . The locations of each marker as well as the YAC and BAC clones of interest within this sequence stretch are indicated, approximately to scale, in this map. Four genes were identi®ed after performing recursive BLAST analysis searches of the GenBank non-redundant database with the markers that mapped to the BAC inserts: the lipoprotein lipase (LPL) gene, the ATPase, H+ transporting, beta polypeptide, isoform 2 (ATP6B2) gene, the solute carrier family 18 (vesicular monoamine) (SLC18A1 or VMAT) gene and the F37/Esophageal cancer related gene-coding leucine zipper motif (FEZ1) gene, now known as LZTS1. Based on the published pattern of expression and the function (when known) of these genes, all except LZTS1 were excluded from further study as potential TSGs. Even though the function of the LZTS1 gene is unknown, it was previously identi®ed as a candidate TSG on the basis of its dierential expression in tumor and normal tissues in several types of cancers (Ishii et al., 1999) . It was isolated originally from a YAC (859A7) that overlaps with YACs 911G7 and 739B2. Its presence in the latter clones, as well as in the BAC clones that suppressed AT6.2 growth, was con®rmed by exon ampli®cation analyses, as shown in Figure 2b . LZTS1 was therefore selected for further studies.
Effects of LZTS1 over-expression on AT6.2 and HEK-293 cells
To examine whether the LZTS1 gene could be responsible for the reduction in cell growth observed following introduction of YACs and BACs into the AT6.2 cells, the complete cDNA and a truncated version (LZTS1-5') were cloned into the mammalian expression vector pcDNA-3.1. These constructs, together with the pEGFPN1 reporter vector, were transfected into the rat prostate cancer cell line AT6.2 and E1-transformed HEK-293 cells. After selection in antibiotic for 3 weeks, a large number of colonies was observed in plates containing cells transfected with the control construct LZTS1-5' plus the reporter vector, or with the reporter vector alone. In contrast, very few colonies were observed in plates transfected with the complete LZTS1 gene ( Figure  3a ,b).
To further verify these results, cell proliferation rates of AT6.2 transfectants were determined. Colonies from each transfectant were collected and seeded in 96-well or 24-well plates at a density of 10 3 or 2610 3 cells/well without G418. After cells were allowed to attach for 16 h, growth rates were determined by counting cells in triplicate wells every 24 h for 4 days. The results indicated that the cell growth rate in culture was dramatically decreased in the LZTS1 transfectants compared to the controls (Figure 3c ,d). Cell viability was usually 495% in the control wells, but much lower in the LZTS1 transfectant wells, although the latter could not be measured accurately because of extensive cell lysis (data not shown). Because few colonies of the LZTS1-transfected HEK-293 cells grew beyond 50 cells per colony, proliferation assays on these cells were not performed.
Effects of LZTS1 expression under different promoters on HEK-293, Rat-1 and RM1 cells
The eects of LZTS1 over-expression were further examined with three cell lines using constructs where transcription was under the control of two dierent promoters. A pBabeHygro/LZTS1 construct was made by cloning the complete LZTS1 cDNA into the pBabeHygro expression vector (Morgenstern and Land, 1990) , where expression is driven by the retroviral gag promoter and hygromycin resistance is used as a selectable marker. Transfection of HEK-293 cells with either this construct or the pCMVNeo/ LZTS1 construct described earlier substantially reduced colony-forming eciency (Figure 4a ,b) compared to the truncated control constructs. In contrast, the colony-forming eciencies of normal Rat-1 ®broblasts and mouse prostate RM1 cells were not inhibited ( Figure 4c ,d and e,f, respectively). In fact, paradoxically, LZTS1 appears to stimulate cellular proliferation in these two cell lines, as indicated by the considerably larger colonies observed in LZTS1 Figure 2 (a) Precise mapping of the location on human chromosome 8p22 of the YAC and BAC clones that exhibited growth-suppressive activity. An ideogram of human chromosome 8 is shown, along with a STS marker map for progressively expanded subregions of &7 Mb and 2 Mb, respectively, containing the LZTS1 gene. The locations of the YAC and BAC clones indicated by vertical bars were inferred from STSs contained within these clones. Approximate distances from the p-telomere are indicated in megabases (Mb), based on the scale of the Human Genome Browser website (http://genome.ucsc.edu). The approximate locations of four known genes (LPL, LZTS1, SLC18A1, and ATP6B2) that have been mapped to the minimal critical subregion encompassed by the BACs are shown. However, some gaps still exist between and within the two sequence contigs spanning this subregion, and thus the distance between some of the markers and genes may be inexact. (b) LZTS1 exon PCR analysis on 8p22 YAC and BAC clones. PCR analysis was performed with DNA prepared from each of the following CTI-BAC (B) clones and YAC (Y) clones: 1, B353G1; 2, B316F10; 3, B353G12; 4, Y911G7; and 5, Y739B2. The primer sets (described in Materials and methods) amplify regions of 0.477, 0.897 and 0.690 Kb from the LZTS1 gene exons 1, 2, and 3, respectively.
Lane M contains DNA molecular size markers (100 bp ladder); sizes are indicated in Kb to the right Functional identification of LZTS1 as a candidate TSG Y Cabeza-Arvelaiz et al transfectant plates. The higher number of colonies in these plates compared to control transfectant plates could be due in part to this increased cell proliferation, which may have led to the formation of satellite colonies. Actually, the large size of these colonies in some plates made it dicult to discriminate between the boundaries of the colonies after 3 weeks of selection.
Different effects of LZTS1 over-expression on human prostate cell lines
To ascertain whether or not these apparently con¯ict-ing eects of LZTS1 on cell growth correlated with the status of endogenous expression, we compared the eect of LZTS1 stable transfection on colony-forming eciency in the human prostate cancer cell lines TSUPr1 and LNCaP. The latter cell line has been shown by Northern blot analysis not to express the full length LZTS1 mRNA (Ishii et al., 1999) . The results of these experiments are shown in Figure 5a . It is obvious that forced expression of the LZTS1 gene strongly abrogated colony formation by the LNCaP cells, whereas in the TSUPr1 cells LZTS1 over-expression slightly increased colony-forming eciency compared to the control. However, when the endogenous LZTS1 expression in these cell lines was checked by RT ± PCR the levels of expression of this gene in both cell lines were comparable; in fact, the only noticeable dierence between these cell lines appeared to be in the expression of the minor isoforms observed in the TSUPr1 cells, as shown in Figure 5b . (Figure 2a ) led to the identi®cation of the LZTS1 gene, previously known as FEZ1 (Ishii et al., 1999) , as potentially responsible for the observed growth inhibitory eects of these clones on AT6.2 cell. Ectopic expression of LZTS1 cDNA in AT6.2 cells resulted in inhibition of colony-forming eciency and a signi®cantly decreased growth rate. These results provide the ®rst direct functional evidence that the LZTS1 gene is involved in the regulation of cell growth and may function as a bona ®de TSG. Transfection of LZTS1 into the HEK-293 and LNCaP cells further con®rmed this gene's capability to negatively regulate cell growth. In the adenovirustransformed HEK-293 cell line, E1B inhibits p53 activity by complex formation. Disruption of the p53/ E1B complexes releases active p53, which induces cell cycle arrest (Hutton et al., 2000) . Thus, it is conceivable that ectopic expression of LZTS1 in HEK-293 cells could disrupt the sequestration of p53 by E1B and lead to growth arrest and/or apoptosis. In fact, there were some observations suggesting that LZTS1 over-expression may promote apoptosis in certain cells. For example, we observed an increased number of cells with sub-diploid DNA content in¯ow-cytometric analysis of LZTS1-transformed AT6.2 cells (not shown). It also appeared that the decrease in the number of GFP+ cells transfected with LZTS1 (Figure 1d ) was likely due to extensive cell loss, rather than segregation of the GFP vector during cell proliferation.
Paradoxically, LZTS1 signi®cantly increased the colony-forming eciency of Rat-1 and RM1 cells and to a lower extent that of TSUPr1 cells. This ambiguous eect could be the result of inactivation of the downstream response to p53 or LZTS1 in these particular cells. For example, such an eect is seen in Rat-1 cells as a result of promoter hypermethylation which prevents expression of p21 WAF1 (Allan et al., 2000) , an eector of p53 apoptotic activity. If p21 WAF1 also mediates the LZTS1 eect, its absence in these cells may avert the LZTS1 growth inhibitory eect. The (ras+myc)-transformed RM1 cells have been shown to be unresponsive to the growth-inhibitory eects of endogenous and exogenous wild-type p53, which indicates that the downstream response to p53 has been inactivated . It would be of interest to investigate the downstream activation of speci®c p53 target genes such as p21 WAF in this cell line. It is also likely that the LZTS1 eects in these cells are partly counteracted by the presence of myc, which has been shown to antagonize the eect of TP53 on apoptosis and p21 WAF1 transactivation in K562 leukemia cells and LNCaP cells (Ceballos et al., 2000; Mitchell and El-Deiry, 1999 ). The TSUPr1 cell line carries an oncogenic mutation in the ras (V12) gene. The presence of activated ras in this and other prostate cell lines has recently been shown to abrogate the upregulation of p21 WAF1 transcription by TGF-b 1 (Park et al., 2000) . Alternatively, similar functional dualism has been seen with several transcription factors and oncoproteins (Evan and Littlewood, 1998; Johnson, 2000; Tuck and Crawford, 1989) . Ectopic expression of E2F, myc or E1A is usually accompanied by apoptosis, which overwhelms the proliferative potential of these genes (Evan and Littlewood, 1998) .
Preliminary studies aimed at elucidating LZTS1 mechanisms by measurement of p53 levels, cdk2 activity and cell DNA content by¯ow cytometry did not produce conclusive evidence implicating this protein in G1 arrest (not shown). However, these transient assays were complicated by the presence of a signi®cant number of untransfected cells in these transient assays. To circumvent these problems we are establishing the system for tetracycline-regulated expression of LZTS1 (Gossen and Bujard, 1992) .
Analyses of the LZTS1 gene and its protein sequence detected features that resemble those of transcription factors, which make it tempting to conjecture a possible role for LZTS1 in gene transcription modulation. For example, the overall structural topography of LZTS1 (Figure 6 ) is reminiscent of the structure of the bZip transcription factors CREB/ATF and CREM (Courey and Tjian, 1988; Foulkes and Sassone-Corsi, 1996; Habener, 1990; Molina et al., 1993; Pirrotta et al., 1987) . Although we detected no recognizable DNA binding motifs in the LZTS1 protein, it should be noted that some transcription modulators do not bind to DNA directly, but can still in¯uence transcription by complex stabilization (Tsai et al., 1987) .
Several transcription factor genes also achieve multitasking through alternative splicing (Chiu et al., 1989; Courey and Tjian, 1988; Foulkes and SassoneCorsi, 1996; Lucibello et al., 1989) . For example, substoichiometric levels of the repressor isoform SCREMb strongly antagonize the activation by the complete CREM protein (Laoide et al., 1993) . The LZTS1 gene also appears to produce multiple transcripts ( Figure 6 ) that could potentially play a role in its mechanism of action by antagonizing the activity of the major isoform. BLAST searches against the human EST database identi®ed seven isoforms (or aberrant transcripts) which we grouped into three types (A, B, and C), according to the location of the dierentially spliced region (Figure 6 ). Type A transcripts are apparently generated through selective splicing at non-canonical splice sites¯anking the sequence stretch coding for the LZ1 motif within exon 2. They maintain co-linearity with genomic DNA across the intronic region immediately after exon 2, and may represent a relatively abundant aberrant transcript since three (17%) out of a total of 18 ESTs that encompassed this region were detected. EST transcript types B and C may represent segments of previously described isoforms (Ishii et al., 1999) , which are shown to scale at the bottom of Figure 6 to illustrate that they could generate the bands detected in the RT ± PCR analysis of TSUPr1 cells RNA. AF123658 and AF12357 would produce 0.650 and 0.617 Kb fragments, respectively, by ampli®cation with the exon 3 primers. Similarly, other as yet uncharacterized, isoforms alternatively spliced at exon 3 could generate the other observed bands of 0.35 and 0.25 Kb. As shown in Figure 6 , in most isoforms the selectively spliced stretches contain the LZ and/or Q-rich motifs. This suggests that the degree of neutralization of the endogenously expressed levels of full-length LZTS1 may be determined by the levels of expression of Figure 6 The upper part shows the organization of the LZTS1 gene and the location of predicted protein motifs. The coding and non-coding sequences (represented by ®lled and open boxes, respectively) of the LZTS1 cDNA (GenBank accession #AF123659) were aligned to the LZTS1 gene sequence (accession #AF123653). The location and relative size of exons and introns (shown as solid lines) are shown to scale. The locations of predicted functional domains in the encoded protein, including a phosphorylation box (P-Box), leucine zippers (LZ), and glutamine-rich (Q) domains, are indicated with arrows. In the middle are shown schematic representations of dierent LZTS1 isoforms and aberrant transcripts in the GenBank human EST database. At least seven of the 29 LZTS1 EST containing coding sequences in the database were alternatively spliced at cryptic splice sites, and three maintained co-linearity with genomic DNA across intronic regions. The structure and location of these presumptive isoforms and aberrant transcripts are depicted as black or hatched boxes (transcribed exon or intron sequences, respectively) and dashed lines (spliced intronic sequences). The types (A, B, and C) and GenBank accession numbers are indicated on the left and right of each EST, respectively. The bottom part of the ®gure shows an expanded representation of six dierent LZTS1 isoforms previously reported as aberrant transcripts by Ishii et al. (1999) . The location and relative sizes of exons and introns are shown to scale; spliced regions are indicated by dashed lines. The GenBank accession numbers are shown on the right. The scale at the bottom of the diagram indicates the approximate positions of the nucleotide residues in the LZTS1 gene isoforms, which could also explain the lack of inhibitory eects by LZTS1 in TSUPr1 cells (Figure  5a,b) .
In summary, we have identi®ed a functional eect of LZTS1 by forced expression of this gene in various cell lines that results in cell growth suppression and possibly apoptosis. The apparent contradictory role of LZTS1 in other cell lines could re¯ect the complex interactions between its dierent isoforms with positive and negative regulators of cell growth that determine the ultimate outcome in terms of cell cycle arrest, cell growth or apoptosis in each cell type. These results support the notion that since regulation of cell proliferation is intimately connected to the control of apoptosis, both activities can be aected by the loss of TSG function and may be critical factors in prostate carcinogenesis.
Materials and methods
Cell lines and culture conditions
AT6.2, a highly metastatic, rat prostate cell line was provided by Dr J Isaacs (Johns Hopkins University, Baltimore, MD, USA). This cell line has previously been used in microcellmediated chromosome transfer to infer the presence of prostate TSGs on human chromosome 8 (Ichikawa et al., 1994) . Rat-1, a spontaneously immortalized rat ®broblast cell line was obtained from American Type Culture Collection (ATCC, Rockville, MD, USA). RM1 is a mouse prostate cell line transformed with myc and ras (Baley et al., 1995) . The human embryonic kidney cell line (HEK-293), transformed with adenovirus type 5 E1 genes, as well as the human prostate cancer cell lines LNCaP and TSUPr1 were obtained from ATCC. Cells were maintained in a 5% CO 2 environment at 378C, in complete medium RPMI 1640 or D-MEM with 2 mM L-glutamine (Life Technologies, Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum (Life Technologies) in the presence of 0.4% antibiotic-antimycotic mixture (Life Technologies).
YAC and BAC identification and selection
YAC clones used in the present study were identi®ed by PCR-based screening (Chinault, 1994) of human genomic YAC libraries (Albertsen et al., 1990; Bellanne-Chantelot et al., 1992 ). An extensive YAC contig was constructed for the 8p22 region by combining veri®ed STS content data from the literature (Bookstein et al., 1994; Chumakov et al., 1995) and supplemental data ®les from the Whitehead Institute/MIT Center for Genome Research (htpp://www.genome.wi.mit.edu) with additional PCR-based library screening results. A subset of overlapping YACs giving complete coverage of the region of interest was chosen for further studies. The 204E7 YAC used as a control contains the human TP53 gene from chromosome 17. A human BAC library (CTI-B; Research Genetics, Huntsville, AL, USA) was screened by ®lter hybridization with overgo probes. To verify that they contained the region of overlap of the two 8p22 YACs (911G7 and 739B2), clones identi®ed by positive ®lter hybridization were screened by whole cell PCR for the following 8p22 markers: WI-5962, WI-4688, WI-5355, WI-4873, WI-9031, LPL, D8S1715, D8S258, stSG10118, WI-9078 , and stSG30884. BAC reporter constructs containing a GFP marker gene were kindly provided by Dr M Cotten (IMP, Vienna, Austria).
YAC modification and spheroplast fusion to AT6.2 cells
A homologous recombination approach using the polyethylene glycol (PEG) transformation method (Burgers and Percival, 1987) was used to retro®t 8p22 and control TP53 YACs with the pRAN4 vector (Markie et al., 1993) containing the aminoglycoside phosphotransferase (neo) gene, which confers resistance to neomycin/G418. Prior to use, YACs were characterized to determine if they had been successfully retro®tted with the neo gene by PCR analysis using the following primers: neo-F:ccagagtcccgctcagaagaactc and neo-R:cttgctcctgccgagaaagtatcc. To show that they retained the sequences of interest, Southern analysis of PFGE-resolved chromosomes was conducted with a neo DNA probe and labeled total human genomic DNA or TP53 cDNA. The neo-retro®tted YACs were fused to AT6.2 cells using previously described protocols for spheroplast fusion (Markie et al., 1993; Pachnis et al., 1990) . A total of 1 ± 5610 7 AT6.2 cells was fused to a 20-fold excess (2 ± 10610 8 ) of spheroplasted yeast cells suspended in STC buer (1 M sorbitol, 10 mM Tris-HCl pH 7.5 and 10 mM CaCl 2 ). The fusion mix was resuspended in 4 ml of 50% PEG-4000 solution (Boehringer Mannheim), 10 mM CaCl 2 , 75 mM HEPES, pH 7.4) and after 120 s at room temperature, 20 ml of RPMI 1640 medium was added and the cells were collected. Cells were resuspended in complete medium and plated over 20 100-mm dishes. Selection was performed in complete medium plus 600 mg/ml of G418 (Life Technologies); discrete resistant colonies usually appeared after 14 ± 21 days. Colony formation was appraised by categorizing the plates, according to the observed number and size of the G418 r colonies in each plate, into three groups: (1) Plates with no colonies or very few colonies (0 ± 5), small in size; (2) Plates with a moderate number of colonies (6 ± 50) of varying size including medium size (30 ± 50 cells) and large size (450 cells); (3) Plates with more than 50 colonies of various sizes including semicon¯uent plates.
BAC preparation and transfection
BAC DNA was isolated using a large scale preparation method (Kirschner and Stratakis, 1999) . BAC transfection into AT6.2 cells used psoralen inactivated adenovirus particles as DNA carrier and polyethyleneimine (PEI, Mol. wt. 2000, Fluka) as condensing agent. The transfection complexes were prepared as previously described (Baker and Cotten, 1997) , except that 4 mg of each BAC and 2 mg of reporter BAC were used for each transfection and the amount of adenovirus particles used was reduced (2610 9 particles/reaction). Cells were kept in serum free medium for 6 h and then refed with complete medium. To monitor the number of GFP+ cells in each plate, at days 1 and 5 posttransfection the transfectants were examined by¯uorescent microscopy using a Nikon Labophot-2¯uorescent microscope (Nikon Inc., Melville, NY, USA), and pictures were taken using a special ®lter set to visualize GFP (CHROMA Technology Corp., Battleboro, VT, USA).
LZTS1 RT ± PCR and exon amplification
For reverse transcription (RT)-PCR, 100 ng of normal human prostate or testis poly(A) + RNA (Clontech, Palo Alto, CA, USA) or 2 mg of total RNA was used to synthesize ®rst-strand cDNA using the SuperScript TM preampli®cation system (Life Technologies) with an oligo(dT) primer. Transcripts were ampli®ed by thermal cycling for 35 cycles using the ELONGASE TM kit (Life Technologies), with the forward (F) and reverse (R) primer set (5'?3'): LZTS1F3 (gtgggaggtgtgtgccagaagtc) and LZTS1R3 (gatatcgccaggtccccagac). Ampli®cation of LZTS1 exon 1 (0.48 Kb) or exon 2 (0.9 Kb) from genomic DNA was performed using the following forward (F) and reverse (R) primers (5'?3'): LZTS1F1: ccctcacggagccacgactgc, LZTS1R1: tcctgcgtttccaacccactt; LZTS1F2: gaaatgggctccgagaagggtg, LZTS1R2: cacgctattggccagcaccag. Ampli®cation of exon 3 (0.7 kb) was done with the LZTS1F3 and R3 primers used above.
Expression and control plasmids, transfections and cell proliferation assays
The pCNeoLZTS1 and pCNeoLZTS1-5' plasmids contain the wild-type complete FEZ1(LZTS1) cDNA coding region (obtained from Dr C Croce, Kimmel Institute for Cancer Research, Philadelphia, PA, USA) and a truncated LZTS1 cDNA (missing exon 3, which encodes the leucine zipper domain), respectively, cloned into the pcDNA-3.1 vector (Invitrogen, San Diego, CA, USA). The pBHygroLZTS1 plasmid contains the complete LZTS1 cDNA cloned into the pBABEHygro expression vector (Morgenstern and Land, 1990) . The expression of the inserted gene in the pcDNA-3.1 and pBABE vectors is driven by the human cytomegalovirus (CMV) promoter and by the retroviral gag promoters, respectively. The GFP reporter vector pEGFP-N1 was obtained from Clontech. The pCNKLC control plasmid contains the kinesin light chain cDNA from plasmid pLBL1 (Cabeza-Arvelaiz et al., 1993) , cloned into pcDNA3.1.
Cells were transfected using 3 ml lipofectamine reagent (2 mg/ml) according to the manufacturer's instructions (Life Technologies) with the indicated amounts of endotoxin-free plasmid DNA, puri®ed with the Endofree kit from QIAGEN (Valencia, CA, USA). For all transient transfections, the cells were incubated in serum free medium for 6 h and then refed complete medium. Cells were transiently co-transfected with 0.5 mg of reporter pEGFP-N1 plasmid and 2 mg of the plasmid containing the complete LZTS1 cDNA or the control plasmids in 35 mm plates. At 16 ± 24 h and on the fourth day post-transfection cells were visualized with a Labophot-2¯uorescent microscope (Nikon Inc), and pictures were taken using a GFP ®lter set (CHROMA Technology).
For 100 mm plates, cells were transfected with 5 mg of plasmid DNA, using 15 ml lipofectamine reagent. For the study of stable colony formation G-418 (600 mg/ml) or hygromycin (200 mg/ml) selection was started 48 h posttransfection and continued for 2 weeks, changing the medium every other day until colonies were counted.
Cell proliferation assays were performed with AT6.2 transfectants. Colonies from each transfectant were collected (LZTS1 transfectant colonies were pooled to have enough cells to perform the assay) and cells were seeded in 96-well or 24-well plates at a density of 10 3 or 2610 3 cells/well without G418 and allowed to attach for 16 h. Triplicate wells from each control and LZTS1-transfected cells were counted at this point to assess the plating eciency of each clone. Although slightly lower than the number originally plated the number of cells was quite similar in all of the wells counted. Cell viability was determined by Trypan blue exclusion to be 93 ± 95% in all wells. Triplicate wells from each clone were counted every 24 h for 4 days to determine the proliferation rate of each transfectant.
Computer-assisted homology and motif searches and alignments BLAST analysis searches were performed with sequences from the EST and STS markers (from the Unigene database: htpp://www.ncbi.nlm.gov/Unigene/) that map to the 911G7 YAC and the BAC CTIB-353G1 against the non-redundant (nr) GenBank database (http://www.ncbi.nlm.nih.gov/Genbank/) to identify sequenced genes, BACs, and ESTs mapped to the critical region. The sequence of the LZTS1 gene (derived from BAC RPCI-11 353K12 on contig accession #NT_008015 and gene AF123653) was used to perform BLASTn search analyses (Altschul et al., 1990) of the human EST database.
